Cristal N.  Downing net worth and biography

Cristal Downing Biography and Net Worth

Insider of Merck & Co., Inc.

Cristal Downing joined Merck as executive vice president and chief communications & public affairs officer in 2021. In this role, Cristal leads Merck’s Corporate Affairs organization and is responsible for the development, advancement and execution of the company’s communications, public affairs, and Environmental, Social and Governance (ESG) efforts. Guided by business priorities and dedication to all who depend on the company’s lifesaving and life-changing work, Cristal is focused on fostering a deep understanding of Merck’s scientific contributions and impact on global health, ensuring public policy priorities stay aligned with business priorities, and enabling strategic engagement and impactful outcomes with a broad range of internal and external stakeholders.  

Most recently, Cristal was vice president, Communications & Public Affairs, Medical Devices, at Johnson & Johnson, where she fortified and amplified the strategy that conveys how the business is elevating the standard of patient care. Prior to that, she held the role of vice president, Global Finance Communications at Johnson & Johnson, where she partnered with the chief financial officer to implement communications and public affairs strategies that enabled the CFO and CEO strategic platforms.

Cristal also co-led the development and implementation of “Our Race to Health Equity” — Johnson & Johnson’s Racial & Social Justice strategy. She has more than 20 years of leadership expertise and capabilities, working in dynamic and complex organizations, including American Express, JP Morgan Chase, and Wells Fargo.

Cristal is a member of the board of trustees for the Ronald McDonald House of Central & Northern New Jersey and is affiliated with several key communications associations. Cristal received her bachelor of arts degree in communications from Monmouth University.

What is Cristal N. Downing's net worth?

The estimated net worth of Cristal N. Downing is at least $622,629.80 as of February 6th, 2025. Ms. Downing owns 7,085 shares of Merck & Co., Inc. stock worth more than $622,630 as of March 25th. This net worth approximation does not reflect any other investments that Ms. Downing may own. Learn More about Cristal N. Downing's net worth.

How do I contact Cristal N. Downing?

The corporate mailing address for Ms. Downing and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at investor_relations@merck.com. Learn More on Cristal N. Downing's contact information.

Has Cristal N. Downing been buying or selling shares of Merck & Co., Inc.?

During the last quarter, Cristal N. Downing has sold $209,562.36 of Merck & Co., Inc. stock. Most recently, Cristal N. Downing sold 2,361 shares of the business's stock in a transaction on Thursday, February 6th. The shares were sold at an average price of $88.76, for a transaction totalling $209,562.36. Following the completion of the sale, the insider now directly owns 7,085 shares of the company's stock, valued at $628,864.60. Learn More on Cristal N. Downing's trading history.

Who are Merck & Co., Inc.'s active insiders?

Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Michael Holston (EVP), Rita Karachun (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), and Wendell Weeks (Director). Learn More on Merck & Co., Inc.'s active insiders.

Are insiders buying or selling shares of Merck & Co., Inc.?

During the last year, Merck & Co., Inc. insiders bought shares 1 times. They purchased a total of 2,833 shares worth more than $250,012.25. During the last year, insiders at the sold shares 1 times. They sold a total of 2,361 shares worth more than $209,562.36. The most recent insider tranaction occured on February, 6th when Director Inge G Thulin bought 2,833 shares worth more than $250,012.25. Insiders at Merck & Co., Inc. own 0.1% of the company. Learn More about insider trades at Merck & Co., Inc..

Information on this page was last updated on 2/6/2025.

Cristal N. Downing Insider Trading History at Merck & Co., Inc.

See Full Table

Cristal N. Downing Buying and Selling Activity at Merck & Co., Inc.

This chart shows Cristal N Downing's buying and selling at Merck & Co., Inc. by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$210ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200k-$100k$0$100k$200kTotal Insider BuyingTotal Insider Selling

Merck & Co., Inc. Company Overview

Merck & Co., Inc. logo
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Read More

Today's Range

Now: $87.88
Low: $87.08
High: $92.31

50 Day Range

MA: $92.83
Low: $83.01
High: $100.72

2 Week Range

Now: $87.88
Low: $81.04
High: $134.63

Volume

20,632,114 shs

Average Volume

10,243,650 shs

Market Capitalization

$221.99 billion

P/E Ratio

13.06

Dividend Yield

3.42%

Beta

0.35